Florence Chaverneff, PhD, Author at Clinical Advisor

doctor inputting information into computer

AHA Online Opioid Education Course Available

By

February 4, 2019

The American Heart Association launched in December 2018 a 30 minute-long online course titled “Opioid Education for Healthcare Providers.”

Pain Information Center

FDA Takes Steps to Reconcile Needs of Patients With Chronic Pain, Efforts to Curb Opioid Epidemic

By

Florence Chaverneff, PhD

July 11, 2018

A panel discussion event held at the US Food and Drug Administration gathered patients with chronic pain and FDA officials, to reconcile concerns around prescriptions of opioid medications with the needs of these patient populations.

Pain Information Center

FDA Cracks Down on Illegal Online Sales of Opioids

By

Florence Chaverneff, PhD

June 8, 2018

The U.S. Food and Drug Administration has issued warnings to 9 online companies selling illegal opioid medications on 53 websites, in direct violation of the Federal Food, Drug, and Cosmetic Act.

Drug Update

Naloxone Recalled Due to Potential Health Risks

By

Florence Chaverneff, PhD

June 7, 2018

Two lots of naloxone hydrochloride injections, USP have been recalled by Hospira, Inc., due to concerns regarding the presence of particulates on the syringe plunger.

Pain Information Center

Pain, Psychiatric Comorbidities More Common in Chronic vs Episodic Migraine

By

Florence Chaverneff, PhD

May 8, 2018

Individuals with chronic vs episodic migraine may be more likely to experience chronic back pain, chronic pain, neck pain, anxiety, and depression.

Pain Information Center

Helping to End Addiction: NIH Initiative Addresses Opioid Epidemic

By

Florence Chaverneff, PhD

April 23, 2018

National Institutes of Health Director, Francis Collins, MD, PhD, announced on April 4, 2018 the launch of the Helping to End Addiction Long-Term Initiative.

AAAAI 2018 Annual Meeting

Asthma, allergic rhinitis prevalence with long-term opioid use

By

Florence Chaverneff, PhD

March 5, 2018

Patients with opioid dependence or abuse may exhibit a higher prevalence of asthma compared with the general population.

Pain Management Information Center

NASEM report outlines strategy to combat opioid epidemic

By

Florence Chaverneff, PhD

July 18, 2017

The FDA commissioned the report to provide an update on current evidence on research, care, and education in the pain field, and to identify actionable measures for the FDA to more adequately address the ongoing opioid epidemic.